Drug
Copanlisib hydrochloride clinical trials
Also written BAY 80-6946 Dihydrochloride and Copanlisib Dihydrochloride.
A product of Copanlisib; its studies count on that page too.
- studies test it
- 8
- open now
- 0
- in phase 3
- 0
- first study started
- 2015
How studies write it
Studies that test it under each name
Studies by the year they started
8 studies that test it; most in 2019 (2)
| Year | Studies |
|---|---|
| 2015 | 1 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 0 · Other 8
National Cancer Institute (NCI) (7) · City of Hope Medical Center (1)
Often tested with
Tested in the same studies.
Nivolumab (2) · Olaparib (2) · Adavosertib (1) · Afatinib (1) · Binimetinib (1) · Capivasertib (1) · Crizotinib (1) · Dabrafenib (1)
Related medicines
As reviewed, each with the page that says it.
- A salt or form of Copanlisib
Studies
Open first, then newest update. How each study uses copanlisib hydrochloride is read from its arms, and is right about nine times in ten.
Testing it · 8
- Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)Active, not recruitingPhase 2National Cancer Institute (NCI)NCT02465060Written as Copanlisib Hydrochloride
- Testing the Combination of the Anti-cancer Drugs Copanlisib, Olaparib, and MEDI4736 (Durvalumab) in Patients With Advanced Solid Tumors With Selected MutationsActive, not recruitingPhase 1National Cancer Institute (NCI)NCT03842228Written as Copanlisib Hydrochloride
- Testing the Addition of Copanlisib to Usual Treatment (Fulvestrant and Abemaciclib) in Metastatic Breast CancerActive, not recruitingPhase 1National Cancer Institute (NCI)NCT03939897Written as Copanlisib Hydrochloride
- Testing the Addition of Copanlisib to Eribulin in Metastatic Triple Negative Breast CancerActive, not recruitingPhase 1/2National Cancer Institute (NCI)NCT04345913Written as Copanlisib Hydrochloride
- Testing Copanlisib as a Potential Targeted Treatment in Cancers With PIK3CA Mutations (MATCH-Subprotocol Z1F)Active, not recruitingPhase 2National Cancer Institute (NCI)NCT05490771Written as Copanlisib Hydrochloride
- Copanlisib and Venetoclax for the Treatment of Relapsed or Refractory Mantle Cell LymphomaActive, not recruitingPhase 1/2City of Hope Medical CenterNCT04939272Written as Copanlisib Hydrochloride
- Copanlisib Hydrochloride and Nivolumab in Treating Patients With Recurrent or Refractory Diffuse Large B-cell Lymphoma or Primary Mediastinal Large B-cell LymphomaCompletedPhase 2National Cancer Institute (NCI)NCT03484819Written as Copanlisib Hydrochloride
- Comparing Standard of Care Chemotherapy Treatment to the Combination of Copanlisib and Olaparib for Recurrent Platinum Resistant Ovarian Cancer That Has Progressed Through PARP Inhibitor TherapyWithdrawnPhase 2National Cancer Institute (NCI)NCT05295589Written as Copanlisib Hydrochloride
Given in every arm · 2 — copanlisib hydrochloride is usual care beside what is tested
- Testing the Addition of an Anti-cancer Drug, Copanlisib, to the Usual Immunotherapy (Nivolumab With or Without Ipilimumab) in Patients With Advanced Solid Cancers That Have Changes in the Following Genes: PIK3CA and PTENActive, not recruitingPhase 1/2National Cancer Institute (NCI)NCT04317105Written as Copanlisib Hydrochloride
- Direct Tumor Microinjection and FDG-PET in Testing Drug Sensitivity in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma, Hodgkin Lymphoma, or Stage IV Breast CancerTerminatedPhase 1Mayo ClinicNCT03432741Written as Copanlisib Hydrochloride
Codes
What other systems call copanlisib hydrochloride · ClinicalTrials.gg INT014153
- Wikidata Q27247597copanlisib hydrochlorideOne source Wikidata
- NCI Thesaurus C138994Copanlisib HydrochlorideOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| Wikidata | Q27247597 | copanlisib hydrochloride | One source Wikidata |
| NCI Thesaurus | C138994 | Copanlisib Hydrochloride | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.